Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Mar 28, 2025; 31(12): 100155
Published online Mar 28, 2025. doi: 10.3748/wjg.v31.i12.100155
Table 3 Factors associated with adherence to recommendations for the first follow-up colonoscopy and computed tomography scan, n (%)
The 1st surveillance colonoscopy
P valueMultivariate analysis OR (95%CI)P value
CT 1
P valueMultivariate analysis OR (95%CI)P value
Yes
No
Yes
No
Average age (Number of patients)66.97 (394)76.69 (131)< 0.0010.91 (0.89-0.94)< 0.00168.7 (483)76.6 (56)< 0.0011.06 (1.03-1.10)< 0.001
SexMale245 (76.6)75 (23.4)0.32299 (91.2)29 (8.8)0.14
Female149 (72.7)56 (27.3)184 (87.2)27 (12.8)
TNM stageI-II248 (77.3)71 (22.3)0.051298 (90.0)33 (10.0)0.69
III141 (70.1)60 (29.9)2.47 (1.46-4.18)< 0.001185 (88.9)23 (11.1)
LocationRight colon119 (73.0)44 (27.0)0.47146 (85.9)24 (14.1)0.051
Left colon275 (76.0)87 (24.0)337 (91.3)32 (8.7)0.80 (0.44-0.15)0.46
SurgeryLaparoscopy111 (87.4)16 (12.6)< 0.001 1122 (94.6)7 (5.4)0.031
Laparotomy283 (71.1)115 (28.9)2.59 (1.43-4.78)0.002361 (88.0)49 (12.0)2.03 (0.87-4.71)0.10
Perioperative complicationsYes42 (65.6)22 (34.4)0.06159 (90.8)6 (9.2)0.68
No352 (76.4)109 (23.6)0.99 (0.52-1.88)0.98424 (89.5)50 (10.5)
Postoperative complicationsYes130 (68.8)59 (31.2)0.011173 (89.2)21 (10.8)0.46
No264 (78.6)72 (21.4)0.76 (0.48-1.20)0.24310 (89.9)35 (10.1)
Adjuvant chemotherapyYes173 (84.8)31 (15.2)< 0.0012.11 (1.18-3.78)0.01197 (96.1)8 (3.9)< 0.0012.46 (1.09-5.54)0.03
No221 (68.8)100 (31.2)1286 (85.6)48 (14.4)1
Neoadjuvant radio-chemotherapyYes63 (91.3)6 (8.7)< 0.0012.18 (0.87-5.50)0.0169 (97.2)2 (2.8)0.032.29 (0.51-10.16)0.28
No331 (72.6)125 (27.4)1414 (88.5)54 (11.5)1